Technologic (r)evolution leads to detection of more sentinel nodes in patients with melanoma in the head and neck region

D.M.S. Berger, Nynke S. van den Berg, Vincent van der Noort, B. van der Hiel, R.A. Valdés Olmos, Tessa Buckle, Gijs H. KleinJan, O.R. Brouwer, L. Vermeeren, B. Karakullukçu, M.W.M. van den Brekel, B.A. van de Wiel, O.E. Nieweg, A.J.M. Balm, F.W.B. van Leeuwen, W.M.C. Klop

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Sentinel lymph node (SN) biopsy (SNB) has proven to be a valuable tool for staging melanoma patients. Since its introduction in the early 1990s, this procedure has undergone several technologic refinements, including the introduction of SPECT/CT, as well as radioguidance and fluorescence guidance. The purpose of the current study was to evaluate the effect of this technologic evolution on SNB in the head and neck region. The primary endpoint was the false-negative (FN) rate. Secondary endpoints were number of harvested SNs, overall operation time, operation time per harvested SN, and postoperative complications. Methods: A retrospective database was queried for cutaneous head and neck melanoma patients who underwent SNB at The Netherlands Cancer Institute between 1993 and 2016. The implementation of new detection techniques was divided into 4 groups: 1993-2005, with preoperative lymphoscintigraphy and intraoperative use of both a γ-ray detection probe and patent blue (n = 30); 2006-2007, with addition of preoperative road maps based on SPECT/CT (n = 15); 2008-2009, with intraoperative use of a portable γ-camera (n = 40); and 2010-2016, with addition of near-infrared fluorescence guidance (n = 192). Results: In total, 277 patients were included. At least 1 SN was identified in all patients. A tumor-positive SN was found in 59 patients (21.3%): 10 in group 1 (33.3%), 3 in group 2 (20.0%), 6 in group 3 (15.0%), and 40 in group 4 (20.8%). Regional recurrences in patients with tumor-negative SNs resulted in an overall FN rate of 11.9% (group 1, 16.7%; group 2, 0%; group 3, 14.3%; group 4, 11.1%). The number of harvested nodes increased with advancing technologies (P = 0.003), whereas Breslow thickness and operation time per harvested SN decreased (P = 0.003 and P = 0.017, respectively). There was no significant difference in percentage of tumor-positive SNs, overall operation time, and complication rate between the different groups. Conclusion: The use of advanced detection technologies led to a higher number of identified SNs without an increase in overall operation time, possibly indicating an improved surgical efficiency. Operation time per harvested SN decreased; the average FN rate remained 11.9% and was unchanged over 23 y. There was no significant change in postoperative complication rate.
Original languageEnglish
Pages (from-to)1357-1362
Number of pages6
JournalThe Journal of Nuclear Medicine
Volume62
Issue number10
DOIs
Publication statusPublished - Oct 2021

Funding

This work is, in part, supported by the Netherlands Organization for Scientific Research: Rubicon grant (019.171LW.022), VIDI grant (STW BGT11272) and a VICI grant (AES BGT 16141) and a European research council-starting grant (ERC-2012-StG-306890). part, supported by

FundersFunder number
Nederlandse Organisatie voor Wetenschappelijk OnderzoekAES BGT 16141, STW BGT11272, 019.171LW.022, ERC-2012-StG-306890

    Fingerprint

    Dive into the research topics of 'Technologic (r)evolution leads to detection of more sentinel nodes in patients with melanoma in the head and neck region'. Together they form a unique fingerprint.

    Cite this